Clinical trial / 2017
Ashwagandha root extract improved memory, executive function, attention, and processing speed in adults with mild cognitive impairment over eight weeks.
A randomized, double-blind, placebo-controlled pilot study evaluated the efficacy and safety of ashwagandha root extract (300 mg twice daily) compared with placebo for eight weeks in 50 adults with mild cognitive impairment. Compared to placebo, the ashwagandha group demonstrated significant improvements in immediate and general memory across multiple Wechsler Memory Scale III subtest scores, including logical memory I (p = 0.007) and II (p = 0.006). Significant improvements were also observed in executive function, sustained attention, and information-processing speed as measured by the Eriksen Flanker task (p = 0.002), Wisconsin Card Sort test (p = 0.014), Trail-Making test part A (p = 0.006), and the Mackworth Clock test (p = 0.009).
- Study type
- Prospective, randomized, double-blind, placebo-controlled study
- Who was studied
- 50 adults with mild cognitive impairment (MCI)
- What was measured
- Memory and cognitive functioning (Wechsler Memory Scale III subtests, executive function, sustained attention, and information-processing speed)
THE PAPER
Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions.
Choudhary D, Bhattacharyya S, Bose S. J Diet Suppl, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.